跳至主要内容
临床试验/NCT05212727
NCT05212727终止不适用

Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders

Innodem Neurosciences1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2022年4月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
300
试验地点
1
主要终点
Symbol Digit Modalities Test (SDMT) score, one time, at the day of enrolment.

研究概览

简要总结

This study aims to develop and validate a sensitive and non-invasive eye-tracking software application.

This study will obtain participant responses to brief cognitive tests designed to evaluate several key functions known to be affected by neurological disorders and non-invasive eye movement measurements in response to visually presented stimuli during specifically designed eye-tracking tests. The study data will be used to develop machine learning algorithms and validate a software application intended to track the progressive component of neurological disorders and associated cognitive changes.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 years old and above
  • A score of ≥ 26 on the Montreal Cognitive Assessment (MoCA)
  • Able to provide informed consent
  • Visual acuity of 20/100 in at least one eye (corrective glasses, contact lenses, surgery etc are permitted).

排除标准

  • Evidence or medical history of psychiatric issues, which are known to also affect movements and oculomotor control.
  • Evidence or history of significant neurological disorder (e.g. MS, PD, ALS, Dementia)
  • Use of prescription drugs known to influence ocular motor visual function, such as benzodiazepines, antipsychotics, and anticonvulsants.
  • Diagnosed with an active substance use disorder.
  • History of stroke.
  • Recent traumatic brain injury (within the last 6 months).

研究组 & 干预措施

Healthy Control

Participant with no evidence or history of significant neurodegenerative disorder affecting brain function.

干预措施: Eye-tracking (Device)

结局指标

主要结局

Symbol Digit Modalities Test (SDMT) score, one time, at the day of enrolment.

时间窗: Baseline

The SDMT is used to assess divided attention, visual scanning, tracking and motor speed. Using a reference key, the examinee has 90 seconds to pair specific numbers with given geometric figures. Scoring involves summing the number of correct substitutions within the 90 second interval.

次要结局

  • Multiple sclerosis functional composite (MSFC) score, one time, at the day of enrolment.(Baseline)
  • The Mini-Mental State Exam (MMSE) score, one time, at the day of enrolment.(Baseline)
  • The Hopkins Verbal Learning Test-Revised (HVLT-R) score, one time, at the day of enrolment.(Baseline)
  • The Controlled Oral Word Association Test (COWAT) score, one time, at the day of enrolment.(Baseline)
  • Brief International Cognitive Assessment for MS (BICAMS) score, one time, at the day of enrolment.(Baseline)
  • The Beck Anxiety Inventory (BAI), one time at the day of enrolment.(Baseline)
  • The Montreal Cognitive Assessment (MoCA) score, one time, at the day of enrolment.(Baseline)
  • The Trail Making Test (TMT) Parts A & B score, one time, at the day of enrolment.(Baserline)
  • The Functional Assessment of Cancer Therapy - Cognitive Function (FACT-Cog), one time, at the day of enrolment.(Baseline)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验